✦ LIBER ✦

A randomised phase II trial of docetaxel vs docetaxel and irinotecan in patients with stage IIIb–IV non-small-cell lung cancer who failed first-line treatment

✍ Scribed by Wachters, F M; Groen, H J M; Biesma, B; Schramel, F M N H; Postmus, P E; Stigt, J A; Smit, E F

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Phase I/II Trial of Docetaxel and Carbop

✍ Kensuke Kataoka; Ryujiro Suzuki; Hiroyuki Taniguchi; Yasunobu Noda; Joe Shindoh; 📂 Article 📅 2006 🏛 Springer 🌐 English ⚖ 82 KB

Irinotecan plus gemcitabine vs irinoteca

✍ Georgoulias, V; Kouroussis, C; Agelidou, A; Boukovinas, I; Palamidas, P; Stavrin 📂 Article 📅 2004 🏛 Nature Publishing Group 🌐 English ⚖ 120 KB

Phase II trial of gemcitabine and doceta

✍ Masafumi Kawamura; Keisuke Eguchi; Yotaro Izumi; Yasushi Yamato; Teruaki Koike; 📂 Article 📅 2006 🏛 Springer 🌐 English ⚖ 280 KB

Docetaxel/gemcitabine or cisplatin/gemci

✍ D. Binder; H. Schweisfurth; C. Grah; C. Schäper; B. Temmesfeld-Wollbrück; G. Sie 📂 Article 📅 2006 🏛 Springer 🌐 English ⚖ 340 KB

Phase II study of cisplatin, ifosfamide,

✍ Fujita, A; Ohkubo, T; Hoshino, H; Takabatake, H; Tagaki, S; Sekine, K; Abe, S 📂 Article 📅 2003 🏛 Nature Publishing Group 🌐 English ⚖ 89 KB

A randomised phase II trial of two seque

✍ Francesco Grossi; Filippo de Marinis; Vittorio Gebbia; Ferdinando Riccardi; Oraz 📂 Article 📅 2011 🏛 Springer 🌐 English ⚖ 241 KB